AI-powered drug discovery platform for rapid molecule screening and testing, from target identification to lab validation. Automating biotech R&D. About Optic Optic started as an AI research team developing high-performance similarity search algorithms. Today our proprietary AI-technology is powering products in multiple industries from blockchain to biotech.
| Website | https://bioptic.io/ |
| Revenue | $7.7 million |
| Employees | 281 (28 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Ai Drug Discovery, Drug Development, R&D Automation, Target Identification, Biotech Automation, Drug Testing, Biotechnology, Ai Platform, Lab Automation, High Throughput Screening, Pharmaceutical, Molecular Testing, Machine Learning, Precision Medicine, In Silico Drug Design, Computational Biology, Deep Learning |
| Competitors | Clarifai, Eagle Eye, Machine Vision Products, Inc., OPTIMETRICS, INC, LUMA TECHNOLOGIES, Insight Laboratories, Visual Insights , Inc., SmartEye, Next Gen Imaging, LLC, PixelPerfectCraft Services +8 more (view full list) |
Looking for a particular OPTIC employee's phone or email?
The OPTIC annual revenue was $7.7 million in 2026.
Andrey Doronichev is the Founder, CEO of OPTIC.
28 people are employed at OPTIC.
OPTIC is based in San Francisco, California.